Medical
Novo Nordisk Halves Ozempic Price for Americans Paying Out of Pocket
Novo Nordisk (Nasdaq: NVO) made headlines today with a move that could mark a turning point for self-paying Americans managing diabetes and obesity. The Danish...
Avicanna Secures New U.S. Patent for Innovative Topical Cannabinoid Skin Treatment
Avicanna (TSX: AVCN, OTCQX: AVCNF) has secured a new patent from the United States Patent and Trademark Office that covers its topical cannabinoid formulation aimed...
MarpaiRx Pushes Pharmacy Benefits Into a New Era of Clarity and Savings
Pharmacy benefits have a reputation for being expensive, confusing, and often leaving both health plans and their members with unanswered questions about where all the...
Funding Moves at Optimi Health Show Confidence Within the Psychedelic Industry
Optimi Health Corp. (CSE: OPTI, OTCQX: OPTHF, FRA: 8BN), a Canadian manufacturer of pharmaceutical-grade MDMA and natural psilocybin, recently announced two key financial arrangements that...
Ascend Wellness Opens New Chapter with Revamped eCommerce and Loyalty Ecosystem
Ascend Wellness Holdings (CSE: AAWH.U, OTCQX: AAWH), known for its footprint across multiple states, has shifted the digital cannabis retail experience with the launch of...
HEALWELL Sharpens Its AI Focus With Full Pentavere Acquisition and Surging Revenue
HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) is making waves in the healthcare technology sector after sharing a glimpse into a robust 2025. The Canadian-based...
Medical City Dallas Hospital Integrates Advanced Tissue Imaging for Surgeries
Medical City Dallas Hospital has started using Perimeter Medical Imaging AI’s (OTCQX: PYNKF) S-Series OCT technology in its operating rooms, marking a new chapter in...
Maven Clinic and Oura Team Up to Bring Wearable Data to Virtual Women’s Health Care
Maven Clinic, recognized as the world’s largest virtual clinic focused on women’s and family health, is taking a significant step forward by partnering with Oura,...
The Shift Toward Gentler and More Effective Cancer Treatments
The pharmaceutical industry is in the midst of a significant shift as antibody-drug conjugates (ADCs) emerge as a promising alternative to traditional chemotherapy for cancer...
Endo Sells International Pharmaceuticals Business to Knight Therapeutics for $105 Million
Endo, Inc. (OTCQX: NDOI) has wrapped up the sale of its International Pharmaceuticals business, marking a significant shift in the company’s focus and portfolio. The...
